Showing results (181-190 of 437) with videos related to

Sort By:
Pageof 44
Blood|January 25, 2002
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantationAmelia A Langston, Istvan Redei, Angela M Caliendo, et al.
Blood Cancer Journal|December 15, 2020
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myelomaYanyan Gu, Benjamin G Barwick, Mala Shanmugam, et al.
Plos One|February 27, 2019
Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft modelsTaofeek K Owonikoko, Guojing Zhang, Shenila B Lallani, et al.
Oncotarget|April 7, 2016
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growthJiusheng Deng, Dongkyoo Park, Mengchang Wang, et al.
European Journal of Medicinal Chemistry|August 25, 2017
Development of GLUT4-selective antagonists for multiple myeloma therapyChangyong Wei, Richa Bajpai, Horrick Sharma, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Majority of human circulating plasmablasts stop blasting: A probable misnomerDoan C Nguyen, Celia Saney, Ian T Hentenaar, et al.
Oncotargets and Therapy|September 3, 2025
The Role of CELMoD Agents in Multiple MyelomaNiels W C J van de Donk, Nizar J Bahlis, Charlotte Pawlyn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2012
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trialSagar Lonial, Mojtaba Akhtari, Jonathan Kaufman, et al.
Blood Cancer Journal|February 7, 2025
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug developmentPralay Mukhopadhyay, Hesham A Abdullah, Joanna B Opalinska, et al.
Haematologica|August 13, 2013
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studiesDavid Siegel, Thomas Martin, Ajay Nooka, et al.
Pageof 44